Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment.

Alzheimer's & dementia (Amsterdam, Netherlands)

Clark DG, McLaughlin PM, Woo E, Hwang K, Hurtz S, Ramirez L, Eastman J, Dukes RM, Kapur P, DeRamus TP, Apostolova LG.
PMID: 27239542
Alzheimers Dement (Amst). 2016 Feb 15;2:113-22. doi: 10.1016/j.dadm.2016.02.001. eCollection 2016.

INTRODUCTION: The objective of this study was to assess the utility of novel verbal fluency scores for predicting conversion from mild cognitive impairment (MCI) to clinical Alzheimer's disease (AD).METHOD: Verbal fluency lists (animals, vegetables, F, A, and S) from...

Cite
Clark DG, McLaughlin PM, Woo E, et al. Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment. Alzheimers Dement (Amst). 2016;2:113-22doi: 10.1016/j.dadm.2016.02.001.
Clark, D. G., McLaughlin, P. M., Woo, E., Hwang, K., Hurtz, S., Ramirez, L., Eastman, J., Dukes, R. M., Kapur, P., DeRamus, T. P., & Apostolova, L. G. (2016). Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment. Alzheimer's & dementia (Amsterdam, Netherlands), 2113-22. https://doi.org/10.1016/j.dadm.2016.02.001
Clark, David Glenn, et al. "Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 2 (2016): 113-22. doi: https://doi.org/10.1016/j.dadm.2016.02.001
Clark DG, McLaughlin PM, Woo E, Hwang K, Hurtz S, Ramirez L, Eastman J, Dukes RM, Kapur P, DeRamus TP, Apostolova LG. Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment. Alzheimers Dement (Amst). 2016 Feb 15;2:113-22. doi: 10.1016/j.dadm.2016.02.001. eCollection 2016. PMID: 27239542; PMCID: PMC4879664.
Copy Download .nbib Format: NLM
Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation.

Hematology reports

Apostolova M, Weng B, Pote HH, Ashcraft H, Goldblatt C, Woolley PV.
PMID: 23355938
Hematol Rep. 2012 Nov 19;4(4):e20. doi: 10.4081/hr.2012.e20.

Skin necrosis and limb gangrene are occasional thrombotic manifestations of anticoagulation therapy. We report a man heterozygous for the Factor V Leiden (FVL) mutation, and with a history of recurrent deep venous thrombosis, who initially presented with a necrotic...

Cite
Apostolova M, Weng B, Pote HH, et al. Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation. Hematol Rep. 2012;4(4):e20doi: 10.4081/hr.2012.e20.
Apostolova, M., Weng, B., Pote, H. H., Ashcraft, H., Goldblatt, C., & Woolley, P. V. (2012). Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation. Hematology reports, 4(4), e20. https://doi.org/10.4081/hr.2012.e20
Apostolova, Mariya, et al. "Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation." Hematology reports vol. 4,4 (2012): e20. doi: https://doi.org/10.4081/hr.2012.e20
Apostolova M, Weng B, Pote HH, Ashcraft H, Goldblatt C, Woolley PV. Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation. Hematol Rep. 2012 Nov 19;4(4):e20. doi: 10.4081/hr.2012.e20. PMID: 23355938; PMCID: PMC3555208.
Copy Download .nbib Format: NLM
A rare case of infectious mononucleosis complicated by guillain-barre syndrome.

Neurology international

Kennedy M, Apostolova M.
PMID: 23888210
Neurol Int. 2013 Jun 27;5(2):20-2. doi: 10.4081/ni.2013.e7. Print 2013 Jun 25.

Infectious mononucleosis is a clinical syndrome characterized by fever, lymphadenopathy and pharyngitis. Neurologic complications of infectious mononucleosis, such as the development of Guillain-Barre syndrome, have been rarely reported and usually present late in the course of the disease. We...

Cite
Kennedy M, Apostolova M. A rare case of infectious mononucleosis complicated by guillain-barre syndrome. Neurol Int. 2013;5(2):20-2doi: 10.4081/ni.2013.e7.
Kennedy, M., & Apostolova, M. (2013). A rare case of infectious mononucleosis complicated by guillain-barre syndrome. Neurology international, 5(2), 20-2. https://doi.org/10.4081/ni.2013.e7
Kennedy, Margaret, and Apostolova, Mariya. "A rare case of infectious mononucleosis complicated by guillain-barre syndrome." Neurology international vol. 5,2 (2013): 20-2. doi: https://doi.org/10.4081/ni.2013.e7
Kennedy M, Apostolova M. A rare case of infectious mononucleosis complicated by guillain-barre syndrome. Neurol Int. 2013 Jun 27;5(2):20-2. doi: 10.4081/ni.2013.e7. Print 2013 Jun 25. PMID: 23888210; PMCID: PMC3718247.
Copy Download .nbib Format: NLM
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography.

Alzheimer's & dementia (Amsterdam, Netherlands)

Risacher SL, Tallman EF, West JD, Yoder KK, Hutchins GD, Fletcher JW, Gao S, Kareken DA, Farlow MR, Apostolova LG, Saykin AJ.
PMID: 29159268
Alzheimers Dement (Amst). 2017 Sep 23;9:57-66. doi: 10.1016/j.dadm.2017.09.001. eCollection 2017.

INTRODUCTION: We investigated the association between olfactory identification and Alzheimer's disease biomarkers, including amyloid, tau, and neurodegeneration.METHODS: Thirty-four older adults, including 19 cognitively normal (CN), 10 subjective cognitive decline (SCD), and 5 mild cognitive impairment, underwent amyloid positron emission...

Cite
Risacher SL, Tallman EF, West JD, et al. Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography. Alzheimers Dement (Amst). 2017;9:57-66doi: 10.1016/j.dadm.2017.09.001.
Risacher, S. L., Tallman, E. F., West, J. D., Yoder, K. K., Hutchins, G. D., Fletcher, J. W., Gao, S., Kareken, D. A., Farlow, M. R., Apostolova, L. G., & Saykin, A. J. (2017). Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography. Alzheimer's & dementia (Amsterdam, Netherlands), 957-66. https://doi.org/10.1016/j.dadm.2017.09.001
Risacher, Shannon L, et al. "Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 9 (2017): 57-66. doi: https://doi.org/10.1016/j.dadm.2017.09.001
Risacher SL, Tallman EF, West JD, Yoder KK, Hutchins GD, Fletcher JW, Gao S, Kareken DA, Farlow MR, Apostolova LG, Saykin AJ. Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography. Alzheimers Dement (Amst). 2017 Sep 23;9:57-66. doi: 10.1016/j.dadm.2017.09.001. eCollection 2017. PMID: 29159268; PMCID: PMC5675709.
Copy Download .nbib Format: NLM
An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.

EJNMMI research

Hofheinz F, Bütof R, Apostolova I, Zöphel K, Steffen IG, Amthauer H, Kotzerke J, Baumann M, van den Hoff J.
PMID: 26936768
EJNMMI Res. 2016 Dec;6(1):19. doi: 10.1186/s13550-016-0174-y. Epub 2016 Mar 02.

BACKGROUND: The standardized uptake value (SUV) is the nearly exclusive means for quantitative evaluation of clinical [18F-]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) whole body investigations. However, the SUV methodology has well-known shortcomings. In this context, it has been recognized...

Cite
Hofheinz F, Bütof R, Apostolova I, et al. An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res. 2016;6(1):19doi: 10.1186/s13550-016-0174-y.
Hofheinz, F., Bütof, R., Apostolova, I., Zöphel, K., Steffen, I. G., Amthauer, H., Kotzerke, J., Baumann, M., & van den Hoff, J. (2016). An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI research, 6(1), 19. https://doi.org/10.1186/s13550-016-0174-y
Hofheinz, Frank, et al. "An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET." EJNMMI research vol. 6,1 (2016): 19. doi: https://doi.org/10.1186/s13550-016-0174-y
Hofheinz F, Bütof R, Apostolova I, Zöphel K, Steffen IG, Amthauer H, Kotzerke J, Baumann M, van den Hoff J. An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res. 2016 Dec;6(1):19. doi: 10.1186/s13550-016-0174-y. Epub 2016 Mar 02. PMID: 26936768; PMCID: PMC4775714.
Copy Download .nbib Format: NLM
Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment.

Dementia and geriatric cognitive disorders extra

Goukasian N, Porat S, Blanken A, Avila D, Zlatev D, Hurtz S, Hwang KS, Pierce J, Joshi SH, Woo E, Apostolova LG.
PMID: 31572424
Dement Geriatr Cogn Dis Extra. 2019 Aug 13;9(2):281-293. doi: 10.1159/000490044. eCollection 2019.

We analyzed structural magnetic resonance imaging data from 58 cognitively normal and 101 mild cognitive impairment subjects. We used a general linear regression model to study the association between cognitive performance with hippocampal atrophy and ventricular enlargement using the...

Cite
Goukasian N, Porat S, Blanken A, et al. Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2019;9(2):281-293doi: 10.1159/000490044.
Goukasian, N., Porat, S., Blanken, A., Avila, D., Zlatev, D., Hurtz, S., Hwang, K. S., Pierce, J., Joshi, S. H., Woo, E., & Apostolova, L. G. (2019). Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dementia and geriatric cognitive disorders extra, 9(2), 281-293. https://doi.org/10.1159/000490044
Goukasian, Naira, et al. "Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment." Dementia and geriatric cognitive disorders extra vol. 9,2 (2019): 281-293. doi: https://doi.org/10.1159/000490044
Goukasian N, Porat S, Blanken A, Avila D, Zlatev D, Hurtz S, Hwang KS, Pierce J, Joshi SH, Woo E, Apostolova LG. Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2019 Aug 13;9(2):281-293. doi: 10.1159/000490044. eCollection 2019. PMID: 31572424; PMCID: PMC6751474.
Copy Download .nbib Format: NLM
Prediction of Lipophilicity and Pharmacokinetics of Chloroacetamides by Chemometric Approach.

Iranian journal of pharmaceutical research : IJPR

Vastag G, Apostolov S, Matijević B.
PMID: 29755543
Iran J Pharm Res. 2018;17(1):100-114.

In this study, the existence of biological potential of selected

Cite
Vastag G, Apostolov S, Matijević B. Prediction of Lipophilicity and Pharmacokinetics of Chloroacetamides by Chemometric Approach. Iran J Pharm Res. 2018;17(1):100-114
Vastag, G., Apostolov, S., & Matijević, B. (2018). Prediction of Lipophilicity and Pharmacokinetics of Chloroacetamides by Chemometric Approach. Iranian journal of pharmaceutical research : IJPR, 17(1), 100-114.
Vastag, Gyöngyi, et al. "Prediction of Lipophilicity and Pharmacokinetics of Chloroacetamides by Chemometric Approach." Iranian journal of pharmaceutical research : IJPR vol. 17,1 (2018): 100-114.
Vastag G, Apostolov S, Matijević B. Prediction of Lipophilicity and Pharmacokinetics of Chloroacetamides by Chemometric Approach. Iran J Pharm Res. 2018;17(1):100-114. PMID: 29755543; PMCID: PMC5937082.
Copy Download .nbib Format: NLM
Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation.

JGH open : an open access journal of gastroenterology and hepatology

Vasudevan A, Ardalan ZS, Ahmed N, Apostolov R, Gow PJ, Testro AG, Gane EJ, Angus PW.
PMID: 30619939
JGH Open. 2018 Sep 19;2(6):288-294. doi: 10.1002/jgh3.12086. eCollection 2018 Dec.

BACKGROUND AND AIMS: Limitations to the use of long-term Hepatitis B Immunoglobulin (HBIg) following liver transplantation for hepatitis B (HBV) have led to the substitution of HBIg with oral nucleo(s)tide analogue prophylaxis. We prospectively assessed the long-term safety and...

Cite
Vasudevan A, Ardalan ZS, Ahmed N, et al. Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation. JGH Open. 2018;2(6):288-294doi: 10.1002/jgh3.12086.
Vasudevan, A., Ardalan, Z. S., Ahmed, N., Apostolov, R., Gow, P. J., Testro, A. G., Gane, E. J., & Angus, P. W. (2018). Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation. JGH open : an open access journal of gastroenterology and hepatology, 2(6), 288-294. https://doi.org/10.1002/jgh3.12086
Vasudevan, Abhinav, et al. "Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation." JGH open : an open access journal of gastroenterology and hepatology vol. 2,6 (2018): 288-294. doi: https://doi.org/10.1002/jgh3.12086
Vasudevan A, Ardalan ZS, Ahmed N, Apostolov R, Gow PJ, Testro AG, Gane EJ, Angus PW. Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation. JGH Open. 2018 Sep 19;2(6):288-294. doi: 10.1002/jgh3.12086. eCollection 2018 Dec. PMID: 30619939; PMCID: PMC6308096.
Copy Download .nbib Format: NLM
The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ.

International journal of molecular sciences

Tzoneva R, Georgieva I, Ivanova N, Uzunova V, Nenchovska Z, Apostolova S, Stoyanova T, Tchekalarova J.
PMID: 34884567
Int J Mol Sci. 2021 Nov 25;22(23). doi: 10.3390/ijms222312763.

One of the pathological hallmarks of Alzheimer's disease (AD) associated with its progression that contributes to β-amyloid (Aβ) generation is oxidative stress (OS). Clinical data suggest that melatonin is a potent antioxidant that might be effective in the adjunctive...

Cite
Tzoneva R, Georgieva I, Ivanova N, et al. The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312763.
Tzoneva, R., Georgieva, I., Ivanova, N., Uzunova, V., Nenchovska, Z., Apostolova, S., Stoyanova, T., & Tchekalarova, J. (2021). The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312763
Tzoneva, Rumiana, et al. "The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312763
Tzoneva R, Georgieva I, Ivanova N, Uzunova V, Nenchovska Z, Apostolova S, Stoyanova T, Tchekalarova J. The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ. Int J Mol Sci. 2021 Nov 25;22(23). doi: 10.3390/ijms222312763. PMID: 34884567; PMCID: PMC8657444.
Copy Download .nbib Format: NLM
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.

Rheumatology (Oxford, England)

Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O'Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R.
PMID: 34689208
Rheumatology (Oxford). 2021 Nov 03;60(11):5483. doi: 10.1093/rheumatology/keab616.

No abstract available.

Cite
Oldroyd AGS, Allard AB, Callen JP, et al. Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021;60(11):5483doi: 10.1093/rheumatology/keab616.
Oldroyd, A. G. S., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., George, M. D., Gordon, P., Kolstad, K., Kurtzman, D. J. B., Machado, P. M., McHugh, N. J., Postolova, A., Selva-O'Callaghan, A., Schmidt, J., Tansley, S., Vleugels, R. A., Werth, V. P., & Aggarwal, R. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford, England), 60(11), 5483. https://doi.org/10.1093/rheumatology/keab616
Oldroyd, Alexander G S, et al. "Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies." Rheumatology (Oxford, England) vol. 60,11 (2021): 5483. doi: https://doi.org/10.1093/rheumatology/keab616
Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O'Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R. Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021 Nov 03;60(11):5483. doi: 10.1093/rheumatology/keab616. PMID: 34689208; PMCID: PMC8623712.
Copy Download .nbib Format: NLM
New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3.

Pharmaceuticals (Basel, Switzerland)

Atanasov G, Rusew RI, Gelev VM, Chanev CD, Nikolova R, Shivachev BL, Petrov OI, Apostolova MD.
PMID: 34959731
Pharmaceuticals (Basel). 2021 Dec 20;14(12). doi: 10.3390/ph14121331.

Here, we describe the synthesis, characterization, and biological activities of a series of 26 new styryl-2(3H)-benzothiazolone analogs of combretastatin-A4 (CA-4). The cytotoxic activities of these compounds were tested in several cell lines (EA.hy926, A549, BEAS-2B, MDA-MB-231, HT-29, MCF-7, and...

Cite
Atanasov G, Rusew RI, Gelev VM, et al. New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3. Pharmaceuticals (Basel). 2021;14(12)doi: 10.3390/ph14121331.
Atanasov, G., Rusew, R. I., Gelev, V. M., Chanev, C. D., Nikolova, R., Shivachev, B. L., Petrov, O. I., & Apostolova, M. D. (2021). New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3. Pharmaceuticals (Basel, Switzerland), 14(12), . https://doi.org/10.3390/ph14121331
Atanasov, Gjorgji, et al. "New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3." Pharmaceuticals (Basel, Switzerland) vol. 14,12 (2021). doi: https://doi.org/10.3390/ph14121331
Atanasov G, Rusew RI, Gelev VM, Chanev CD, Nikolova R, Shivachev BL, Petrov OI, Apostolova MD. New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3. Pharmaceuticals (Basel). 2021 Dec 20;14(12). doi: 10.3390/ph14121331. PMID: 34959731.
Copy Download .nbib Format: NLM
Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment.

Clinical nuclear medicine

Lange C, Mäurer A, Suppa P, Apostolova I, Steffen IG, Grothe MJ, Buchert R.
PMID: 35006106
Clin Nucl Med. 2022 Feb 01;47(2):123-129. doi: 10.1097/RLU.0000000000003981.

PURPOSE: The aim of this study was to evaluate brain FDG PET for short- to medium-term prediction of cognitive decline, need for assisted living, and survival in acutely hospitalized geriatric patients with newly detected clinically uncertain cognitive impairment (CUCI).MATERIALS...

Cite
Lange C, Mäurer A, Suppa P, et al. Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment. Clin Nucl Med. 2022;47(2):123-129doi: 10.1097/RLU.0000000000003981.
Lange, C., Mäurer, A., Suppa, P., Apostolova, I., Steffen, I. G., Grothe, M. J., & Buchert, R. (2022). Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment. Clinical nuclear medicine, 47(2), 123-129. https://doi.org/10.1097/RLU.0000000000003981
Lange, Catharina, et al. "Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment." Clinical nuclear medicine vol. 47,2 (2022): 123-129. doi: https://doi.org/10.1097/RLU.0000000000003981
Lange C, Mäurer A, Suppa P, Apostolova I, Steffen IG, Grothe MJ, Buchert R. Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment. Clin Nucl Med. 2022 Feb 01;47(2):123-129. doi: 10.1097/RLU.0000000000003981. PMID: 35006106.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries